Science Diabetes mellitus

Enying Gong 1, Shaira Baptista 1 2, Anthony Russell 3 4, Paul Scuffham 5, Michaela Riddell 6, Jane Speight 1 2 7, Dominique Bird 4, Emily Williams 8, Mojtaba Lotfaliany 1, Brian Oldenburg 1 Main idea: The MDC program was successfully adopted and used by individuals with type 2 diabetes and significantly improved the users’ […]

Shengwei Wang 1, Hao Cui 2, Keshan Ji 3, Changpeng Song 3, Changwei Ren 1, Hongchang Guo 1, Changsheng Zhu 4, Shuiyun Wang 5, Yongqiang Lai 6 Main idea: Hypertrophic cardiomyopathy patients with and without type 2 diabetes mellitus have similar 3-year cardiovascular mortality after septal myectomy. However, type 2 diabetes mellitus is associated with […]

Masato Furuhashi 1, Ichiro Sakuma 2, Takeshi Morimoto 3, Yukimura Higashiura 4, Akiko Sakai 4, Megumi Matsumoto 4, Mio Sakuma 3, Michio Shimabukuro 5, Takashi Nomiyama 6, Osamu Arasaki 7, Koichi Node 8, Shinichiro Ueda 9 Main idea: Anagliptin decreases serum FABP4 concentration independent of change in hemoglobin A1c or LDL-C in patients with type […]

Deepak L Bhatt 1, Michael Szarek 1, P Gabriel Steg 1, Christopher P Cannon 1, Lawrence A Leiter 1, Darren K McGuire 1, Julia B Lewis 1, Matthew C Riddle 1, Adriaan A Voors 1, Marco Metra 1, Lars H Lund 1, Michel Komajda 1, Jeffrey M Testani 1, Christopher S Wilcox 1, Piotr Ponikowski […]

Christopher P Cannon 1, Richard Pratley 1, Samuel Dagogo-Jack 1, James Mancuso 1, Susan Huyck 1, Urszula Masiukiewicz 1, Bernard Charbonnel 1, Robert Frederich 1, Silvina Gallo 1, Francesco Cosentino 1, Weichung J Shih 1, Ira Gantz 1, Steven G Terra 1, David Z I Cherney 1, Darren K McGuire 1, VERTIS CV Investigators Main […]

Yue Zhou 1, Yajing Huang 1, Xiaoyun Ji 1, Xiang Wang 1, Liyan Shen 1, Yangang Wang 1 Main idea: Pioglitazone should be considered in patients with or at high risk of T2DM for the prevention of cardiovascular endpoints, especially in those with a history of established CVD who might benefit the most. Robust reductions […]

Hsin-Hung Chen 1 2, Ching-Chu Chen 3 4, Chun-Wei Ho 1, Ming-Chia Hsieh 1 5 6, Sheng-Pang Hsu 3, Cheng-Li Lin 7 8, Chia-Hung Kao 9 10 11 12 Main idea: For public health issue with type2 diabetes and infection, DPP4i use decreased Klebsiella pneumoniae pneumonia. Male gender, patients with co-morbidities, patients with higher DSCI […]

Jean-Philippe Drouin-Chartier 1 2 3 4, Amanda L Schwab 1, Siyu Chen 1, Yanping Li 1, Frank M Sacks 1 5, Bernard Rosner 1 5 6, JoAnn E Manson 5 7 8, Walter C Willett 1 5 8, Meir J Stampfer 1 5 8, Frank B Hu 1 5 8, Shilpa N Bhupathiraju 1 5 […]

Jeannie Tay 1, Campbell H Thompson 2, Natalie D Luscombe-Marsh 3, Manny Noakes 3, Jonathan D Buckley 4, Gary A Wittert 2, Grant D Brinkworth 5 Main idea: In free-living individuals with type 2 diabetes, nutrition biomarkers within normal ranges at baseline did not change significantly after 2 years on a prescribed low-carbohydrate or high-carbohydrate […]

Szimonetta Lohner 1, Daniela Kuellenberg de Gaudry 2, Ingrid Toews 3, Tamas Ferenci 4, Joerg J Meerpohl 3 5 Main idea: There is inconclusive evidence of very low certainty regarding the effects of NNS consumption compared with either sugar, placebo, or nutritive low-calorie sweetener consumption on clinically relevant benefit or harm for HbA1c, body weight, […]